Draft guidance on management of rolling reviews for drug submissions: Overview
This guidance helps sponsors interpret amendments to the Food and Drug Regulations (regulations) that allow a sponsor to apply for rolling review status for a forthcoming drug submission that meets specific eligibility conditions.
- Publisher
- Health Canada
- Resources
- 2
- Catalogue metadata updated
- 2023-09-01
Data overview
- Formats
- HTML
- File languages
- English, French